The purpose of the study is to see if a new investigational medication can control inflammation, mucous production and difficulty breathing in people who continue to have asthma symptoms despite daily treatment with inhaled corticosteroids (e.g., Flovent) or inhaled corticosteroids with long-acting beta agonists and/or long-acting muscarinic antagonists (e.g., Advair). Participants cannot be on Prednisone for six weeks before the trial begins.
Study participation involves:
- Two visits over 7-8 days
- Blood draw
- Spirometry at no cost to you
- Study medication at no cost to you